Data is not available at this time.
N2OFF, Inc. operates in the agricultural technology sector, focusing on innovative solutions to reduce nitrous oxide (N2O) emissions, a potent greenhouse gas. The company's core revenue model is driven by licensing its proprietary technology and forming strategic partnerships with agricultural producers and food companies. Its flagship product, a bio-based seed treatment, aims to enhance crop yields while minimizing environmental impact, positioning N2OFF as a niche player in the sustainable agtech space. The company targets large-scale farming operations and collaborates with research institutions to validate its technology's efficacy. Despite its small scale, N2OFF differentiates itself through a science-backed approach to emissions reduction, addressing a critical need in climate-conscious agriculture. The agtech industry is highly competitive, but N2OFF's specialized focus on N2O mitigation provides a unique value proposition in a market increasingly driven by regulatory and sustainability pressures.
N2OFF reported modest revenue of $210,000 for the period, reflecting its early-stage commercialization efforts. The company posted a net loss of $5.2 million, with an EPS of -$0.89, indicating significant investment in R&D and market penetration. Operating cash flow was negative at $3.4 million, underscoring the cash-intensive nature of its growth phase. Capital expenditures were negligible, suggesting a lean operational model focused on intellectual property rather than physical assets.
The company's negative earnings highlight its pre-revenue stage, with losses driven by high R&D and operational costs. Capital efficiency remains a challenge, as evidenced by the substantial cash burn relative to revenue. However, the lack of significant debt and minimal capital expenditures suggest a strategic focus on preserving liquidity while scaling its technology.
N2OFF maintains a relatively strong liquidity position with $2.2 million in cash and equivalents, providing a short-term runway. Total debt is minimal at $7,000, indicating low leverage. The absence of dividends aligns with its growth-focused strategy, prioritizing reinvestment over shareholder returns. The balance sheet reflects a typical early-stage biotech profile, with limited liabilities but reliance on future funding to sustain operations.
Growth prospects hinge on the adoption of its emission-reducing technology, which is still in the commercialization phase. The company does not pay dividends, redirecting all resources toward scaling its product offerings and partnerships. Given its niche market, success will depend on regulatory tailwinds and broader agricultural sustainability trends.
Market expectations for N2OFF are speculative, given its early-stage status and limited revenue. Valuation likely incorporates significant growth potential tied to climate-focused agricultural innovations. Investors may view the company as a high-risk, high-reward play on the intersection of agtech and environmental sustainability.
N2OFF's strategic advantage lies in its specialized technology addressing a critical environmental challenge. The outlook depends on its ability to secure partnerships, validate its product at scale, and navigate regulatory landscapes. Success could position it as a leader in sustainable agriculture, though execution risks remain high given the capital-intensive nature of the industry.
Company filings, CIK: 0001789192
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |